lisdexamfetamine dimesylate (LDX), but not 30 mg/d LDX, significantly reduced binge eating days (primary endpoint) in adults with binge eating disorder (BED).
The following search terms were used: lisdexamfetamine, lisdexamfetamine dimesylate, lisdexamphetamine dimesylate, lisdexamphetamine, SPD489, Vyvanse, Elvanse, or LDX and binge, binge-eating disorder, binge eating disorder, binging, bingeing, binge eating, binge-eating, or binge disorder (see supplementary materials for full search terms). The
Lisdexamfetamine may also be used to treat binge eating disorder (BED). It may help to reduce the number of binge eating days.This medication is a stimulant. It is
Moderate to severe binge eating disorder (BED) in adults. Lisdexamfetamine dimesylate may help reduce the number of binge eating days in people with BED. Lisdexamfetamine dimesylate is not for use in children under 6 years of age with ADHD. Lisdexamfetamine dimesylate is not for weight loss. It is not known if lisdexamfetamine dimesylate is
The exact mechanism of lisdexamfetamine in ADHD and binge eating disorder is not known. Lisdexamfetamine dimesylate is a prodrug that is converted to the active
lisdexamfetamine dimesylate for the treatment of binge eating disorder. Licensed under the brand name Vyvanse, lisdexamfetamine is the first
An efficient combination therapy with Lisdexamfetamine dimesylate and Topiramate in improving binge eating scale metabolic profile in binge eating disorder.
The exact mechanism of lisdexamfetamine in ADHD and binge eating disorder is not known. Lisdexamfetamine dimesylate is a prodrug that is converted to the active
binge eating) in both animals and humans. Stimulants such as (lisdexamfetamine) might relieve binge eating in BED by stabilizing a deficient
Comments